Virginie Moucadel

Title: Virginie Moucadel: Innovator in Protein Kinase Inhibition

Introduction

Virginie Moucadel is a notable inventor based in Saint-Egreve, France. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors for protein kinases.

Latest Patents

Moucadel holds a patent for "Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2." This invention relates to the use of specific compounds of formula (I) and their pharmaceutically-acceptable salts as a new family of protein kinase CK2 inhibitors. The invention also encompasses the use of these compounds for the preparation of pharmaceutical compositions aimed at preventing and/or treating various disorders and diseases, including cancers, autoimmune and inflammatory diseases, infectious diseases, diabetes-related angiogenesis disorders, retinopathies, and cardiac hypertrophy. She has 1 patent to her name.

Career Highlights

Throughout her career, Moucadel has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the National Institute of Health and Medical Research. Her work has been instrumental in advancing the understanding of protein kinases and their role in various diseases.

Collaborations

Moucadel has collaborated with notable colleagues, including Claude Cochet and Renaud Prudent, contributing to her research and innovations in the field.

Conclusion

Virginie Moucadel's work in developing protein kinase inhibitors showcases her dedication to advancing medical science. Her contributions have the potential to impact the treatment of various serious health conditions.